Pär Stattin

Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase

Westerberg, Marcus; Holm, Lennart; Garmo, Hans; Stattin, Pär et al.

Part of International Journal of Epidemiology, 2025

• DOI for Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase
• Download full text (pdf) of Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase

Potential gains from radical treatment of men with prostate cancer according to life expectancy

Irenaeus, Sandra; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Part of BJUI Compass, 2025

• DOI for Potential gains from radical treatment of men with prostate cancer according to life expectancy
• Download full text (pdf) of Potential gains from radical treatment of men with prostate cancer according to life expectancy

Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study

Scilipoti, Pietro; Garmo, Hans; Gedeborg, Rolf; Robinson, David et al.

Part of Journal of the National Cancer Institute, p. 1142-1150, 2025

• DOI for Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study
• Download full text (pdf) of Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study

Time trends in Gleason score distribution among Gleason score 8 and 9-10 cancers

Egevad, Lars; Micoli, Chiara; Delahunt, Brett; Samaratunga, Hemamali et al.

Part of Journal of Clinical Pathology, p. 429-431, 2025

• DOI for Time trends in Gleason score distribution among Gleason score 8 and 9-10 cancers

Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Pros tate Cancer-specific Death in Sweden: A Population-based Cohort Study

Zelic, Renata; Westerberg, Marcus; Stattin, Pär; Garmo, Hans et al.

Part of European Urology Open Science, p. 41-50, 2025

• DOI for Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Pros tate Cancer-specific Death in Sweden: A Population-based Cohort Study
• Download full text (pdf) of Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Pros tate Cancer-specific Death in Sweden: A Population-based Cohort Study

Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase

Westerberg, Marcus; Holm, Lennart; Garmo, Hans; Stattin, Pär et al.

Part of International Journal of Epidemiology, 2025

• DOI for Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase
• Download full text (pdf) of Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase

Potential gains from radical treatment of men with prostate cancer according to life expectancy

Irenaeus, Sandra; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Part of BJUI Compass, 2025

• DOI for Potential gains from radical treatment of men with prostate cancer according to life expectancy
• Download full text (pdf) of Potential gains from radical treatment of men with prostate cancer according to life expectancy

Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study

Scilipoti, Pietro; Garmo, Hans; Gedeborg, Rolf; Robinson, David et al.

Part of Journal of the National Cancer Institute, p. 1142-1150, 2025

• DOI for Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study
• Download full text (pdf) of Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study

Time trends in Gleason score distribution among Gleason score 8 and 9-10 cancers

Egevad, Lars; Micoli, Chiara; Delahunt, Brett; Samaratunga, Hemamali et al.

Part of Journal of Clinical Pathology, p. 429-431, 2025

• DOI for Time trends in Gleason score distribution among Gleason score 8 and 9-10 cancers

Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Pros tate Cancer-specific Death in Sweden: A Population-based Cohort Study

Zelic, Renata; Westerberg, Marcus; Stattin, Pär; Garmo, Hans et al.

Part of European Urology Open Science, p. 41-50, 2025

• DOI for Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Pros tate Cancer-specific Death in Sweden: A Population-based Cohort Study
• Download full text (pdf) of Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Pros tate Cancer-specific Death in Sweden: A Population-based Cohort Study

Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate Cancer

Scilipoti, Pietro; Bratt, Ola; Garmo, Hans; Wilberg Orrason, Andri et al.

Part of The Journal of the National Comprehensive Cancer Network, 2025

• DOI for Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate Cancer

Association of height, BMI, and smoking status with prostate cancer risk before and after the introduction of PSA testing in Sweden

Mboya, Innocent B.; Fritz, Josef; Scilipoti, Pietro; Haggstrom, Christel et al.

Part of Scientific Reports, 2025

• DOI for Association of height, BMI, and smoking status with prostate cancer risk before and after the introduction of PSA testing in Sweden
• Download full text (pdf) of Association of height, BMI, and smoking status with prostate cancer risk before and after the introduction of PSA testing in Sweden

Sociodemographic disparities in incidence rates of advanced and low-risk prostate cancer as a proxy for diagnostic activity

Strömberg, Ulf; Bonander, Carl; Garmo, Hans; Lambe, Mats et al.

Part of Acta Oncologica, p. 677-684, 2025

• DOI for Sociodemographic disparities in incidence rates of advanced and low-risk prostate cancer as a proxy for diagnostic activity
• Download full text (pdf) of Sociodemographic disparities in incidence rates of advanced and low-risk prostate cancer as a proxy for diagnostic activity

A comparison of comorbidity indices and estimates of life expectancy for men with prostate cancer

Ventimiglia, Eugenio; Gedeborg, Rolf; Orrason, Andri Wilberg; Zaurito, Paolo et al.

Part of Scandinavian journal of urology, p. 105-107, 2025

• DOI for A comparison of comorbidity indices and estimates of life expectancy for men with prostate cancer
• Download full text (pdf) of A comparison of comorbidity indices and estimates of life expectancy for men with prostate cancer

Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study

Zaurito, Paolo; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Part of Scandinavian journal of urology, p. 93-96, 2025

• DOI for Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study
• Download full text (pdf) of Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study

Radical Treatment for Prostate Cancer in Men With Limited Life Expectancy in Sweden

Ventimiglia, Eugenio; Gedeborg, Rolf; Styrke, Johan; Wilberg Orrason, Andri et al.

Part of JAMA Network Open, 2025

• DOI for Radical Treatment for Prostate Cancer in Men With Limited Life Expectancy in Sweden
• Download full text (pdf) of Radical Treatment for Prostate Cancer in Men With Limited Life Expectancy in Sweden

Functional outcomes after primary vs delayed robot-assisted radical prostatectomy following active surveillance

Corsini, Christian; Scilipoti, Pietro; Orrason, Andri Wilberg; Gedeborg, Rolf et al.

Part of JNCI Cancer Spectrum, 2025

• DOI for Functional outcomes after primary vs delayed robot-assisted radical prostatectomy following active surveillance
• Download full text (pdf) of Functional outcomes after primary vs delayed robot-assisted radical prostatectomy following active surveillance

Gleason scores provide more accurate prognostic information than grade groups

Egevad, Lars; Micoli, Chiara; Delahunt, Brett; Samaratunga, Hemamali et al.

Part of Pathology, p. 293-296, 2025

• DOI for Gleason scores provide more accurate prognostic information than grade groups
• Download full text (pdf) of Gleason scores provide more accurate prognostic information than grade groups

A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer.

Srinivasan, Srilakshmi; Kryza, Thomas; Bock, Nathalie; Tse, Brian W C et al.

Part of Nature Communications, p. 9587, 2024

• DOI for A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer.

Prostatacancerregistret: för patienter, sjukvård och forskning

Franck Lissbrant, Ingela; Styrke, Johan; Törnblom, Magnus; Hjelm Eriksson, Marie et al.

Part of Läkartidningen, 2024

How to improve cancer care by use of guidelines and quality registers

Stattin, Pär

Part of Scandinavian journal of urology, p. 190-192, 2024

• DOI for How to improve cancer care by use of guidelines and quality registers
• Download full text (pdf) of How to improve cancer care by use of guidelines and quality registers

Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study

Westerberg, Marcus; Irenaeus, Sandra; Garmo, Hans; Stattin, Pär et al.

Part of PLOS ONE, 2024

• DOI for Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study
• Download full text (pdf) of Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study

Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trial

Westerberg, Marcus; Garmo, Hans; Robinson, David; Stattin, Pär et al.

Part of Journal of Clinical Epidemiology, 2024

• DOI for Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trial
• Download full text (pdf) of Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trial

Population-based study of disease trajectory after radical treatment for high-risk prostate cancer

Stattin, Pär; Fleming, Sarah; Lin, Xiwu; Lefresne, Florence et al.

Part of BJU International, p. 96-102, 2024

• DOI for Population-based study of disease trajectory after radical treatment for high-risk prostate cancer
• Download full text (pdf) of Population-based study of disease trajectory after radical treatment for high-risk prostate cancer

Prognosis of Gleason Score 9-10 Prostatic Adenocarcinoma in Needle Biopsies: A Nationwide Population-based Study

Egevad, Lars; Micoli, Chiara; Samaratunga, Hemamali; Delahunt, Brett et al.

Part of European Urology Oncology, p. 213-221, 2024

• DOI for Prognosis of Gleason Score 9-10 Prostatic Adenocarcinoma in Needle Biopsies: A Nationwide Population-based Study
• Download full text (pdf) of Prognosis of Gleason Score 9-10 Prostatic Adenocarcinoma in Needle Biopsies: A Nationwide Population-based Study

Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study

Egevad, Lars; Micoli, Chiara; Delahunt, Brett; Samaratunga, Hemamali et al.

Part of Virchows Archiv, p. 995-1003, 2024

• DOI for Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study
• Download full text (pdf) of Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study

Risks of depression, anxiety, and suicide in partners of men with prostate cancer: a national cohort study

Crump, Casey; Stattin, Pär; Brooks, James D.; Sundquist, Jan et al.

Part of Journal of the National Cancer Institute, p. 745-752, 2024

• DOI for Risks of depression, anxiety, and suicide in partners of men with prostate cancer: a national cohort study

Natural History of Nonmetastatic Prostate Cancer Managed With Watchful Waiting

Ventimiglia, Eugenio; Gedeborg, Rolf; Styrke, Johan; Robinson, David et al.

Part of JAMA Network Open, 2024

• DOI for Natural History of Nonmetastatic Prostate Cancer Managed With Watchful Waiting
• Download full text (pdf) of Natural History of Nonmetastatic Prostate Cancer Managed With Watchful Waiting

Socioeconomic inequality in prostate cancer diagnostics, primary treatment, rehabilitation, and mortality in Sweden

Strömberg, Ulf; Berglund, Anders; Carlsson, Stefan; Thellenberg Karlsson, Camilla et al.

Part of International Journal of Cancer, p. 637-645, 2024

• DOI for Socioeconomic inequality in prostate cancer diagnostics, primary treatment, rehabilitation, and mortality in Sweden
• Download full text (pdf) of Socioeconomic inequality in prostate cancer diagnostics, primary treatment, rehabilitation, and mortality in Sweden

Risk of anxiety disorders in men with prostate cancer: a national cohort study

Crump, Casey; Stattin, Pär; Brooks, James D.; Sundquist, Jan et al.

Part of JNCI Cancer Spectrum, 2024

• DOI for Risk of anxiety disorders in men with prostate cancer: a national cohort study
• Download full text (pdf) of Risk of anxiety disorders in men with prostate cancer: a national cohort study

Triggers for transition from active surveillance to radical treatment of prostate cancer 2008-2020 – a case control study

Ahlberg, Mats Steinholtz; Garmo, Hans; Stattin, Pär; Gedeborg, Rolf et al.

Part of Scandinavian journal of urology, 2024

• DOI for Triggers for transition from active surveillance to radical treatment of prostate cancer 2008-2020 – a case control study
• Download full text (pdf) of Triggers for transition from active surveillance to radical treatment of prostate cancer 2008-2020 – a case control study

Temporal trend in risk of prostate cancer death in men with favourable-risk prostate cancer

Thomsen, Frederik F.; Garmo, Hans; Egevad, Lars; Stattin, Pär et al.

Part of Scandinavian journal of urology, p. 76-83, 2024

• DOI for Temporal trend in risk of prostate cancer death in men with favourable-risk prostate cancer
• Download full text (pdf) of Temporal trend in risk of prostate cancer death in men with favourable-risk prostate cancer

Body mass index, triglyceride-glucose index, and prostate cancer death: a mediation analysis in eight European cohorts

Fritz, Josef; Jochems, Sylvia H. J.; Bjorge, Tone; Wood, Angela M. et al.

Part of British Journal of Cancer, p. 308-316, 2024

• DOI for Body mass index, triglyceride-glucose index, and prostate cancer death: a mediation analysis in eight European cohorts
• Download full text (pdf) of Body mass index, triglyceride-glucose index, and prostate cancer death: a mediation analysis in eight European cohorts

Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer: A Register-based Nationwide Study

Corsini, Christian; Bergengren, Oskar; Carlsson, Stefan; Garmo, Hans et al.

Part of European Urology Oncology, p. 605-613, 2024

• DOI for Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer: A Register-based Nationwide Study

Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostatectomy. A nationwide populationbased study

Scilipoti, Pietro; Liedberg, Fredrik; Garmo, Hans; Wilberg Orrason, Andri et al.

Part of Scandinavian journal of urology, p. 98-103, 2024

• DOI for Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostatectomy. A nationwide populationbased study
• Download full text (pdf) of Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostatectomy. A nationwide populationbased study

Time trends for the use of active surveillance and deferred treatment for localised prostate cancer in Sweden: a nationwide study

Maljkovic, Jovana; Bill-Axelson, Anna; Hållberg, Hampus; Berglund, Anders et al.

Part of Scandinavian journal of urology, p. 200-206, 2024

• DOI for Time trends for the use of active surveillance and deferred treatment for localised prostate cancer in Sweden: a nationwide study
• Download full text (pdf) of Time trends for the use of active surveillance and deferred treatment for localised prostate cancer in Sweden: a nationwide study

Response to Lao, Guan, Wang, et al.

Crump, Casey; Stattin, Pär; Brooks, James D.; Sundquist, Jan et al.

Part of Journal of the National Cancer Institute, p. 770-770, 2024

• DOI for Response to Lao, Guan, Wang, et al.

Mortality Risks Associated with Depression in Men with Prostate Cancer

Crump, Casey; Stattin, Pär; Brooks, James D; Sundquist, Jan et al.

Part of European Urology Oncology, p. 1411-1419, 2024

• DOI for Mortality Risks Associated with Depression in Men with Prostate Cancer

Body mass index and risk of over 100 cancer forms and subtypes in 4.1 million individuals in Sweden: the Obesity and Disease Development Sweden (ODDS) pooled cohort study

Sun, Ming; da Silva, Marisa; Bjorge, Tone; Fritz, Josef et al.

Part of The Lancet Regional Health, 2024

• DOI for Body mass index and risk of over 100 cancer forms and subtypes in 4.1 million individuals in Sweden: the Obesity and Disease Development Sweden (ODDS) pooled cohort study
• Download full text (pdf) of Body mass index and risk of over 100 cancer forms and subtypes in 4.1 million individuals in Sweden: the Obesity and Disease Development Sweden (ODDS) pooled cohort study

Evidence of cancer progression as the cause of death in men with prostate cancer in Sweden

Wilberg Orrason, Andri; Styrke, Johan; Garmo, Hans; Stattin, Pär

Part of BJU International, p. 486-493, 2023

• DOI for Evidence of cancer progression as the cause of death in men with prostate cancer in Sweden
• Download full text (pdf) of Evidence of cancer progression as the cause of death in men with prostate cancer in Sweden

Risks of alcohol and drug use disorders in prostate cancer survivors: a national cohort study

Crump, Casey; Stattin, Pär; Brooks, James D.; Sundquist, Jan et al.

Part of JNCI Cancer Spectrum, 2023

• DOI for Risks of alcohol and drug use disorders in prostate cancer survivors: a national cohort study
• Download full text (pdf) of Risks of alcohol and drug use disorders in prostate cancer survivors: a national cohort study

Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study

Jochems, Sylvia H. J.; Fritz, Josef; Häggström, Christel; Jarvholm, Bengt et al.

Part of European Urology, p. 422-431, 2023

• DOI for Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study
• Download full text (pdf) of Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study

Prediagnostic markers of insulin resistance and prostate cancer risk and death: A pooled study

Jochems, Sylvia H. J.; Fritz, Josef; Häggström, Christel; Stattin, Pär et al.

Part of Cancer Medicine, p. 13732-13744, 2023

• DOI for Prediagnostic markers of insulin resistance and prostate cancer risk and death: A pooled study
• Download full text (pdf) of Prediagnostic markers of insulin resistance and prostate cancer risk and death: A pooled study

Frequency of Biopsy and Tumor Grade Before vs After Introduction of Prostate Magnetic Resonance Imaging.

Robinson, David; Abdulkareem, Rafid; Nasrollah, Delshad; Ljung, Anders et al.

Part of JAMA Network Open, 2023

• DOI for Frequency of Biopsy and Tumor Grade Before vs After Introduction of Prostate Magnetic Resonance Imaging.

Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy

Corsini, Christian; Garmo, Hans; Wilberg Orrason, Andri; Gedeborg, Rolf et al.

Part of JAMA Network Open, 2023

• DOI for Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy
• Download full text (pdf) of Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy

Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists

Bonde, Tiago M.; Garmo, Hans; Stattin, Pär; Nilsson, Per et al.

Part of Acta Oncologica, p. 1815-1821, 2023

• DOI for Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists
• Download full text (pdf) of Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists

Thanks and good bye Taylor & Francis, authors and readers see you at Scand J Urol's new website!

Stattin, Pär

Part of Scandinavian journal of urology, p. 1-1, 2023

• DOI for Thanks and good bye Taylor & Francis, authors and readers see you at Scand J Urol's new website!

Welcome to the new Scandinavian Journal of Urology!

Stattin, Pär

Part of Scandinavian journal of urology, 2023

• DOI for Welcome to the new Scandinavian Journal of Urology!
• Download full text (pdf) of Welcome to the new Scandinavian Journal of Urology!

Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden

Gedeborg, Rolf; Sandin, Fredrik; Thellenberg-Karlsson, Camilla; Styrke, Johan et al.

Part of Scandinavian journal of urology, p. 93-100, 2023

• DOI for Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden
• Download full text (pdf) of Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden

Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis

Watts, Eleanor L.; Perez-Cornago, Aurora; Fensom, Georgina K.; Smith-Byrne, Karl et al.

Part of International Journal of Epidemiology, p. 71-86, 2023

• DOI for Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis
• Download full text (pdf) of Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis

Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden

Lin, E.; Garmo, Hans; Hagström, Emil; Van Hemelrijck, Mieke et al.

Part of British Journal of Cancer, p. 814-824, 2023

• DOI for Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden
• Download full text (pdf) of Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden

Stora regionala skillnader i behandlingen av prostatacancer

Stattin, Pär; Gedeborg, Rolf

Part of Läkartidningen, 2023

Long-term Risks of Depression and Suicide Among Men with Prostate Cancer: A National Cohort Study

Crump, Casey; Stattin, Pär; Brooks, James D.; Sundquist, Jan et al.

Part of European Urology, p. 263-272, 2023

• DOI for Long-term Risks of Depression and Suicide Among Men with Prostate Cancer: A National Cohort Study

Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study.

Shore, Richard; Zhang, Ji; Ye, Weimin; Stattin, Pär et al.

Part of Cancer Causes and Control, p. 949-961, 2023

• DOI for Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study.
• Download full text (pdf) of Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study.

Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden.

George, Gincy; Garmo, Hans; Adolfsson, Jan; Elf, Kristin et al.

Part of Journal of Oncology, p. 9527920, 2023

• DOI for Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden.

Design considerations for observational studies of drugs for advanced cancer

Garcia-Albeniz, Xabier; Stattin, Pär; Westerberg, Marcus; Weinrib, Rachel et al.

Part of Pharmacoepidemiology and Drug Safety, p. 812-815, 2023

• DOI for Design considerations for observational studies of drugs for advanced cancer
• Download full text (pdf) of Design considerations for observational studies of drugs for advanced cancer

Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study

Sun, Ming; Fritz, Josef; Häggström, Christel; Bjørge, Tone et al.

Part of Journal of the National Cancer Institute, p. 456-467, 2023

• DOI for Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study
• Download full text (pdf) of Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study

Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.

Westerberg, Marcus; Beckmann, Kerri; Gedeborg, Rolf; Irenaeus, Sandra et al.

Part of Journal of Clinical Epidemiology, p. 22-30, 2023

• DOI for Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.
• Download full text (pdf) of Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.

Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden

Stattin, Pär; Westerberg, Marcus; Lissbrant, Ingela Franck; Eriksson, Marie Hjälm et al.

Part of Clinical Genitourinary Cancer, p. 1070-107000000000, 2023

• DOI for Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden
• Download full text (pdf) of Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden

Susceptibility to SARS-Cov-2 infection and risk for severe COVID-19 in patients with prostate cancer on androgen deprivation therapy

Gedeborg, Rolf; Loeb, Stacy; Styrke, Johan; Kiiski-Berggren, Ritva et al.

Part of International Journal of Cancer, p. 1925-1934, 2022

• DOI for Susceptibility to SARS-Cov-2 infection and risk for severe COVID-19 in patients with prostate cancer on androgen deprivation therapy
• Download full text (pdf) of Susceptibility to SARS-Cov-2 infection and risk for severe COVID-19 in patients with prostate cancer on androgen deprivation therapy

Long-term Outcomes Among Men Undergoing Active Surveillance for Prostate Cancer in Sweden

Ventimiglia, Eugenio; Bill-Axelson, Anna; Bratt, Ola; Montorsi, Francesco et al.

Part of JAMA Network Open, 2022

• DOI for Long-term Outcomes Among Men Undergoing Active Surveillance for Prostate Cancer in Sweden
• Download full text (pdf) of Long-term Outcomes Among Men Undergoing Active Surveillance for Prostate Cancer in Sweden

Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data

Ventimiglia, Eugenio; Bill-Axelson, Anna; Adolfsson, Jan; Aly, Markus et al.

Part of European Urology Open Science, p. 46-51, 2022

• DOI for Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data
• Download full text (pdf) of Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data

Risk of severe late toxicity after radiotherapy following radical prostatectomy - a nationwide study

Braide, Karin; Kindblom, Jon; Karlsson, Camilla Thellenberg; Stattin, Pär et al.

Part of BJU International, p. 799-808, 2022

• DOI for Risk of severe late toxicity after radiotherapy following radical prostatectomy - a nationwide study

Surgeon volume and patient-reported urinary incontinence after radical prostatectomy: Population-based register study in Sweden

Godtman, Rebecka Arnsrud; Persson, Erik; Bergengren, Oskar; Carlsson, Stefan et al.

Part of Scandinavian journal of urology, p. 343-350, 2022

• DOI for Surgeon volume and patient-reported urinary incontinence after radical prostatectomy: Population-based register study in Sweden
• Download full text (pdf) of Surgeon volume and patient-reported urinary incontinence after radical prostatectomy: Population-based register study in Sweden

Reply to Paulius Bosas, Gintaras Zaleskis, and Dainius Characiejus's Letter to the Editor re: Sylvia HJ Jochems, Josef Fritz, Christel Haggstrom, Bengt Jarvholm, Par Stattin, Tanja Stocks. Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.03.033. Therapeutic Monitoring in Prostate Cancer Should Involve a Cotinine Test in Current Smokers

Jochems, Sylvia H. J.; Stattin, Pär; Stocks, Tanja

Part of European Urology, 2022

• DOI for Reply to Paulius Bosas, Gintaras Zaleskis, and Dainius Characiejus's Letter to the Editor re: Sylvia HJ Jochems, Josef Fritz, Christel Haggstrom, Bengt Jarvholm, Par Stattin, Tanja Stocks. Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.03.033. Therapeutic Monitoring in Prostate Cancer Should Involve a Cotinine Test in Current Smokers

Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists

Bonde, Tiago M.; Westerberg, Marcus; Aly, Markus; Eklund, Martin et al.

Part of Scandinavian journal of urology, p. 169-175, 2022

• DOI for Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists
• Download full text (pdf) of Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists

Evidence of cancer progression in men with prostate cancer as the adjudicated cause of death

Orrason, Andri Wilberg; Styrke, Johan; Garmo, Hans; Stattin, Pär

Part of BJU International, 2022

Time difference in retrieving clinical information in Patient-overview Prostate Cancer compared to electronic health records

Alverbratt, Charlotte; Vikman, Hanna; Eriksson, Marie Hjalm; Stattin, Pär et al.

Part of Scandinavian journal of urology, p. 95-101, 2022

• DOI for Time difference in retrieving clinical information in Patient-overview Prostate Cancer compared to electronic health records
• Download full text (pdf) of Time difference in retrieving clinical information in Patient-overview Prostate Cancer compared to electronic health records

Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer

Gedeborg, Rolf; Lindhagen, Lars; Loeb, Stacy; Styrke, Johan et al.

Part of Scandinavian journal of urology, p. 104-111, 2022

• DOI for Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer
• Download full text (pdf) of Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer

Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy

Wilberg Orrason, Andri; Westerberg, Marcus; Albertsen, Peter; Styrke, Johan et al.

Part of PLOS ONE, 2022

• DOI for Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy
• Download full text (pdf) of Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy

Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study

Gedeborg, Rolf; Garmo, Hans; Thellenberg-Karlsson, Camilla; Fallara, Giuseppe et al.

Part of Acta Oncologica, p. 328-332, 2022

• DOI for Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study

Association of Blood Pressure with Prostate Cancer Risk by Disease Severity and Prostate Cancer Death: A Pooled Cohort Study

Jochems, Sylvia H. J.; Häggström, Christel; Stattin, Pär; Järvholm, Bengt et al.

Part of Cancer Epidemiology, Biomarkers and Prevention, p. 1483-1491, 2022

• DOI for Association of Blood Pressure with Prostate Cancer Risk by Disease Severity and Prostate Cancer Death: A Pooled Cohort Study

Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden

Balabanova, Yanina; Farahmand, Bahman; Stattin, Pär; Garmo, Hans et al.

Part of BMC Urology, 2022

• DOI for Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden
• Download full text (pdf) of Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden

The 90-day cause-specific mortality after radical prostatectomy: a nationwide population-based study.

Björklund, Johan; Stattin, Pär; Rönmark, Erik; Aly, Markus et al.

Part of BJU International, p. 318-324, 2022

• DOI for The 90-day cause-specific mortality after radical prostatectomy: a nationwide population-based study.
• Download full text (pdf) of The 90-day cause-specific mortality after radical prostatectomy: a nationwide population-based study.

Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia

Watts, Eleanor L.; Perez-Cornago, Aurora; Fensom, Georgina K.; Smith-Byrne, Karl et al.

Part of International Journal of Cancer, p. 1033-1046, 2022

• DOI for Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia
• Download full text (pdf) of Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia

Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden

Balabanova, Yanina; Farahmand, Bahman; Garmo, Hans; Stattin, Pär et al.

Part of BMJ Open, 2022

• DOI for Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden
• Download full text (pdf) of Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden

Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes

Lin, E.; Garmo, Hans; Van Hemelrijck, Mieke; Zethelius, Björn et al.

Part of JAMA Network Open, 2022

• DOI for Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes
• Download full text (pdf) of Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes

Prostate cancer polygenic risk score and prediction of lethal prostate cancer

Klein, Robert J.; Vertosick, Emily; Sjoberg, Dan; Ulmert, David et al.

Part of npj Precision Oncology, 2022

• DOI for Prostate cancer polygenic risk score and prediction of lethal prostate cancer
• Download full text (pdf) of Prostate cancer polygenic risk score and prediction of lethal prostate cancer

Population-based estimates of age and comorbidity specific life expectancy: a first application in Swedish males

Van Hemelrijck, Mieke; Ventimiglia, Eugenio; Robinson, David; Gedeborg, Rolf et al.

Part of BMC Medical Informatics and Decision Making, 2022

• DOI for Population-based estimates of age and comorbidity specific life expectancy: a first application in Swedish males
• Download full text (pdf) of Population-based estimates of age and comorbidity specific life expectancy: a first application in Swedish males

Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic.

Gedeborg, Rolf; Styrke, Johan; Loeb, Stacy; Garmo, Hans et al.

Part of PLOS ONE, 2021

• DOI for Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic.
• Download full text (pdf) of Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic.

Association of surgeon and hospital volume with short-term outcomes after robot-assisted radical prostatectomy: Nationwide, population-based study

Godtman, Rebecka Arnsrud; Persson, Erik; Cazzaniga, Walter; Sandin, Fredrik et al.

Part of PLOS ONE, 2021

• DOI for Association of surgeon and hospital volume with short-term outcomes after robot-assisted radical prostatectomy: Nationwide, population-based study
• Download full text (pdf) of Association of surgeon and hospital volume with short-term outcomes after robot-assisted radical prostatectomy: Nationwide, population-based study

Prostate cancer grading, time to go back to the future.

Egevad, Lars; Delahunt, Brett; Bostwick, David G; Cheng, Liang et al.

Part of BJU International, p. 165-168, 2021

• DOI for Prostate cancer grading, time to go back to the future.
• Download full text (pdf) of Prostate cancer grading, time to go back to the future.

Waist circumference and a body shape index and prostate cancer risk and mortality

Jochems, Sylvia H. J.; Wood, Angela M.; Häggström, Christel; Orho-Melander, Marju et al.

Part of Cancer Medicine, p. 2885-2896, 2021

• DOI for Waist circumference and a body shape index and prostate cancer risk and mortality

A new Editorial Team for the Scandinavian Journal of Urology

Stattin, Pär

Part of Scandinavian journal of urology, p. 89-89, 2021

• DOI for A new Editorial Team for the Scandinavian Journal of Urology

Time spent in hormone-sensitive and castration-resistant disease states in men with advanced prostate cancer, and its health economic impact: registry-based study in Sweden

Svensson, Johanna; Franck Lissbrant, Ingela; Gauffin, Oskar; Hjälm-Eriksson, Marie et al.

Part of Scandinavian journal of urology, p. 1-8, 2021

• DOI for Time spent in hormone-sensitive and castration-resistant disease states in men with advanced prostate cancer, and its health economic impact: registry-based study in Sweden
• Download full text (pdf) of Time spent in hormone-sensitive and castration-resistant disease states in men with advanced prostate cancer, and its health economic impact: registry-based study in Sweden

Short-term ciprofloxacin prophylaxis for prostate biopsy and risk of aortic aneurysm. Nationwide, population-based cohort study

Lundstrom, Karl-Johan; Garmo, Hans; Gedeborg, Rolf; Stattin, Pär et al.

Part of Scandinavian journal of urology, p. 221-226, 2021

• DOI for Short-term ciprofloxacin prophylaxis for prostate biopsy and risk of aortic aneurysm. Nationwide, population-based cohort study

Prostate cancer diagnosis, staging, and treatment in Sweden during the first phase of the COVID-19 pandemic

Fallara, Giuseppe; Sandin, Fredrik; Styrke, Johan; Carlsson, Stefan et al.

Part of Scandinavian journal of urology, p. 184-191, 2021

• DOI for Prostate cancer diagnosis, staging, and treatment in Sweden during the first phase of the COVID-19 pandemic
• Download full text (pdf) of Prostate cancer diagnosis, staging, and treatment in Sweden during the first phase of the COVID-19 pandemic

Androgen Deprivation Therapy and the Risk for Inguinal Hernia: An Observational Nested Case Control Study

Hermann, Maria; Vikman, Hanna; Stattin, Pär; Katawazai, Asmatullah et al.

Part of American Journal of Men's Health, 2021

• DOI for Androgen Deprivation Therapy and the Risk for Inguinal Hernia: An Observational Nested Case Control Study
• Download full text (pdf) of Androgen Deprivation Therapy and the Risk for Inguinal Hernia: An Observational Nested Case Control Study

Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden

George, Gincy; Vikman, Hanna; Gedeborg, Rolf; Franck Lissbrant, Ingela et al.

Part of Acta Oncologica, p. 459-465, 2021

• DOI for Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden
• Download full text (pdf) of Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden

Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: a nationwide, population-based cohort study

Lin, E.; Garmo, Hans; Van Hemelrijck, Mieke; Adolfsson, Jan et al.

Part of BMC Cancer, 2021

• DOI for Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: a nationwide, population-based cohort study
• Download full text (pdf) of Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: a nationwide, population-based cohort study

The Inverse Association of Body Mass Index with Lung Cancer: Exploring Residual Confounding, Metabolic Aberrations and Within-Person Variability in Smoking

Wood, Angela M.; Jonsson, Håkan; Nagel, Gabriele; Häggström, Christel et al.

Part of Cancer Epidemiology, Biomarkers and Prevention, p. 1489-1497, 2021

• DOI for The Inverse Association of Body Mass Index with Lung Cancer: Exploring Residual Confounding, Metabolic Aberrations and Within-Person Variability in Smoking

A drug comorbidity index to predict mortality in men with castration resistant prostate cancer

Fallara, Giuseppe; Gedeborg, Rolf; Bill-Axelson, Anna; Garmo, Hans et al.

Part of PLOS ONE, 2021

• DOI for A drug comorbidity index to predict mortality in men with castration resistant prostate cancer
• Download full text (pdf) of A drug comorbidity index to predict mortality in men with castration resistant prostate cancer

Variation in Prostate-Specific Antigen Testing Rates and Prostate Cancer Treatments and Outcomes in a National 20-Year Cohort

Bergengren, Oskar; Westerberg, Marcus; Holmberg, Lars; Stattin, Pär et al.

Part of JAMA Network Open, 2021

• DOI for Variation in Prostate-Specific Antigen Testing Rates and Prostate Cancer Treatments and Outcomes in a National 20-Year Cohort
• Download full text (pdf) of Variation in Prostate-Specific Antigen Testing Rates and Prostate Cancer Treatments and Outcomes in a National 20-Year Cohort

Temporal changes in cause-specific death in men with localised prostate cancer treated with radical prostatectomy: a population-based, nationwide study

Thomsen, Frederik B; Garmo, Hans; Brasso, Klaus; Egevad, Lars et al.

Part of Journal of Surgical Oncology, p. 867-875, 2021

• DOI for Temporal changes in cause-specific death in men with localised prostate cancer treated with radical prostatectomy: a population-based, nationwide study
• Download full text (pdf) of Temporal changes in cause-specific death in men with localised prostate cancer treated with radical prostatectomy: a population-based, nationwide study

Comparison of Relative Survival and Cause-Specific Survival in Men With Prostate Cancer According to Age and Risk Category: A Nationwide, Population-Based Study.

Wilberg Orrason, Andri; Garmo, Hans; Styrke, Johan; Dickman, Paul W et al.

Part of American Journal of Epidemiology, p. 2053-2063, 2021

• DOI for Comparison of Relative Survival and Cause-Specific Survival in Men With Prostate Cancer According to Age and Risk Category: A Nationwide, Population-Based Study.
• Download full text (pdf) of Comparison of Relative Survival and Cause-Specific Survival in Men With Prostate Cancer According to Age and Risk Category: A Nationwide, Population-Based Study.

Rapid ascertainment of uptake of a new indication for abiraterone by use of three nationwide health care registries in Sweden

Fallara, Giuseppe; Lissbrant, Ingela Franck; Styrke, Johan; Montorsi, Francesco et al.

Part of Acta Oncologica, p. 56-60, 2021

• DOI for Rapid ascertainment of uptake of a new indication for abiraterone by use of three nationwide health care registries in Sweden

You can't judge a book by the cover

Stattin, Pär

Part of Scandinavian journal of urology, p. 347-347, 2021

• DOI for You can't judge a book by the cover

An Aggregated Comorbidity Measure Based on History of Filled Drug Prescriptions: Development and Evaluation in Two Separate Cohorts

Gedeborg, Rolf; Sund, Malin; Lambe, Mats; Plym, Anna et al.

Part of Epidemiology, p. 607-615, 2021

• DOI for An Aggregated Comorbidity Measure Based on History of Filled Drug Prescriptions: Development and Evaluation in Two Separate Cohorts

Metabolic factors and the risk of small intestine cancers: Pooled study of 800 000 individuals in the metabolic syndrome and cancer project

Nagel, Gabriele; Bjorge, Tone; Jaensch, Andrea; Peter, Raphael S. et al.

Part of International Journal of Cancer, p. 66-74, 2021

• DOI for Metabolic factors and the risk of small intestine cancers: Pooled study of 800 000 individuals in the metabolic syndrome and cancer project
• Download full text (pdf) of Metabolic factors and the risk of small intestine cancers: Pooled study of 800 000 individuals in the metabolic syndrome and cancer project

Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer

Shore, Richard; Yu, Jingru; Ye, Weimin; Lagergren, Jesper et al.

Part of Scientific Reports, 2021

• DOI for Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer
• Download full text (pdf) of Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer

Epidemiology and Prevention of Prostate Cancer

Gandaglia, Giorgio; Leni, Riccardo; Bray, Freddie; Fleshner, Neil et al.

Part of European Urology Oncology, p. 877-892, 2021

• DOI for Epidemiology and Prevention of Prostate Cancer

Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of Sweden

Fallara, Giuseppe; Alverbratt, Charlotte; Garmo, Hans; Vikman, Hanna et al.

Part of Acta Oncologica, p. 1589-1596, 2021

• DOI for Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of Sweden
• Download full text (pdf) of Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of Sweden

Simulation model of disease incidence driven by diagnostic activity

Westerberg, Marcus; Larsson, Rolf; Holmberg, Lars; Stattin, Pär et al.

Part of Statistics in Medicine, p. 1172-1188, 2021

• DOI for Simulation model of disease incidence driven by diagnostic activity
• Download full text (pdf) of Simulation model of disease incidence driven by diagnostic activity

Opioid Use after Radical Prostatectomy: Nationwide, Population Based Study in Sweden

Loeb, Stacy; Cazzaniga, Walter; Robinson, David; Garmo, Hans et al.

Part of Journal of Urology, p. 145-150, 2020

• DOI for Opioid Use after Radical Prostatectomy: Nationwide, Population Based Study in Sweden

Comparative Effectiveness of Different Radical Radiotherapy Treatment Regimens for Prostate Cancer: A Population-Based Cohort Study

Pettersson, Andreas; Alm, Daniel; Garmo, Hans; Hjelm Eriksson, Marie et al.

Part of JNCI Cancer Spectrum, 2020

• DOI for Comparative Effectiveness of Different Radical Radiotherapy Treatment Regimens for Prostate Cancer: A Population-Based Cohort Study
• Download full text (pdf) of Comparative Effectiveness of Different Radical Radiotherapy Treatment Regimens for Prostate Cancer: A Population-Based Cohort Study

Duration of sick leave after active surveillance, surgery or radiotherapy for localised prostate cancer: a nationwide cohort study

Plym, Anna; Clements, Mark; Voss, Margaretha; Holmberg, Lars et al.

Part of BMJ Open, 2020

• DOI for Duration of sick leave after active surveillance, surgery or radiotherapy for localised prostate cancer: a nationwide cohort study
• Download full text (pdf) of Duration of sick leave after active surveillance, surgery or radiotherapy for localised prostate cancer: a nationwide cohort study

Prespecified 4-Kallikrein Marker Model at Age 50 or 60 for Early Detection of Lethal Prostate Cancer in a Large Population Based Cohort of Asymptomatic Men Followed for 20 Years

Vertosick, Emily A.; Häggström, Christel; Sjoberg, Daniel D.; Hallmans, Goran et al.

Part of Journal of Urology, p. 281-287, 2020

• DOI for Prespecified 4-Kallikrein Marker Model at Age 50 or 60 for Early Detection of Lethal Prostate Cancer in a Large Population Based Cohort of Asymptomatic Men Followed for 20 Years

Risk of Postoperative Up Staging or Upgrading among Men with Low Risk Familial Prostate Cancer

Jansson, Fredrik; Folkvaljon, Folke; Stattin, Pär; Bratt, Ola et al.

Part of Journal of Urology, p. 79-81, 2020

• DOI for Risk of Postoperative Up Staging or Upgrading among Men with Low Risk Familial Prostate Cancer

Early-Life Cardiorespiratory Fitness and Long-term Risk of Prostate Cancer

Crump, Casey; Stattin, Pär; Brooks, James D.; Stocks, Tanja et al.

Part of Cancer Epidemiology, Biomarkers and Prevention, p. 2187-2194, 2020

• DOI for Early-Life Cardiorespiratory Fitness and Long-term Risk of Prostate Cancer

Current routines for antibiotic prophylaxis prior to transrectal prostate biopsy: a national survey to all urology clinics in Sweden.

Styrke, Johan; Resare, Sven; Lundström, Karl-Johan; Masaba, Patrick et al.

Part of F1000 Research, 2020

• DOI for Current routines for antibiotic prophylaxis prior to transrectal prostate biopsy: a national survey to all urology clinics in Sweden.
• Download full text (pdf) of Current routines for antibiotic prophylaxis prior to transrectal prostate biopsy: a national survey to all urology clinics in Sweden.

Prescription-based prediction of baseline mortality risk among older men

Gedeborg, Rolf; Garmo, Hans; Robinson, David; Stattin, Pär

Part of PLOS ONE, 2020

• DOI for Prescription-based prediction of baseline mortality risk among older men
• Download full text (pdf) of Prescription-based prediction of baseline mortality risk among older men

Overall survival and second primary malignancies in men with metastatic prostate cancer

Mehtälä, Juha; Zong, Jihong; Vassilev, Zdravko; Brobert, Gunnar et al.

Part of PLOS ONE, 2020

• DOI for Overall survival and second primary malignancies in men with metastatic prostate cancer
• Download full text (pdf) of Overall survival and second primary malignancies in men with metastatic prostate cancer

Set-up and preliminary results from the Patient-overview Prostate Cancer: Longitudinal registration of treatment of advanced prostate cancer in the National Prostate Cancer Register of Sweden

Lissbrant, Ingela Franck; Eriksson, Marie Hjalm; Lambe, Mats; Tornblom, Magnus et al.

Part of Scandinavian journal of urology, p. 227-234, 2020

• DOI for Set-up and preliminary results from the Patient-overview Prostate Cancer: Longitudinal registration of treatment of advanced prostate cancer in the National Prostate Cancer Register of Sweden
• Download full text (pdf) of Set-up and preliminary results from the Patient-overview Prostate Cancer: Longitudinal registration of treatment of advanced prostate cancer in the National Prostate Cancer Register of Sweden

Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998-2016

Beckmann, Kerri; Garmo, Hans; Nilsson, Per; Franck Lissbrant, Ingela et al.

Part of Acta Oncologica, p. 549-557, 2020

• DOI for Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998-2016
• Download full text (pdf) of Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998-2016

Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in Sweden

Orrason, Andri Wilberg; Westerberg, Marcus; Garmo, Hans; Lissbrant, Ingela Franck et al.

Part of BJU International, p. 142-151, 2020

• DOI for Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in Sweden
• Download full text (pdf) of Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in Sweden

5 alpha-Reductase Inhibitors and Risk of Prostate Cancer Death

Miranda, Tiago Bonde; Garmo, Hans; Stattin, Pär; Robinson, David

Part of Journal of Urology, p. 714-719, 2020

• DOI for 5 alpha-Reductase Inhibitors and Risk of Prostate Cancer Death

Long-term adherence to GnRH agonists in men with prostate cancer: A nation-wide population-based study in prostate cancer data base Sweden

George, Gincy; Garmo, Hans; Rudman, Sarah; Holmberg, Lars et al.

Part of Scandinavian journal of urology, p. 20-26, 2020

• DOI for Long-term adherence to GnRH agonists in men with prostate cancer: A nation-wide population-based study in prostate cancer data base Sweden
• Download full text (pdf) of Long-term adherence to GnRH agonists in men with prostate cancer: A nation-wide population-based study in prostate cancer data base Sweden

Predicting Prostate Cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort Study

Zelic, Renata; Garmo, Hans; Zugna, Daniela; Stattin, Pär et al.

Part of European Urology, p. 180-188, 2020

• DOI for Predicting Prostate Cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort Study

Single institution followed by national implementation of systematic surgical quality control and feedback for radical prostatectomy: a 20-year journey

Stranne, J; Axen, E; Franck-Lissbrant, I; Fransson, P et al.

Part of World journal of urology, p. 1397-1411, 2020

• DOI for Single institution followed by national implementation of systematic surgical quality control and feedback for radical prostatectomy: a 20-year journey
• Download full text (pdf) of Single institution followed by national implementation of systematic surgical quality control and feedback for radical prostatectomy: a 20-year journey

Prostate cancer in kidney transplant recipients - a nationwide register study.

Bratt, Ola; Drevin, Linda; Prütz, Karl-Göran; Carlsson, Stefan et al.

Part of BJU International, p. 679-685, 2020

• DOI for Prostate cancer in kidney transplant recipients - a nationwide register study.
• Download full text (pdf) of Prostate cancer in kidney transplant recipients - a nationwide register study.

The triglyceride-glucose index as a measure of insulin resistance and risk of obesity-related cancers

Fritz, Josef; Bjørge, Tone; Nagel, Gabriele; Manjer, Jonas et al.

Part of International Journal of Epidemiology, p. 193-204, 2020

• DOI for The triglyceride-glucose index as a measure of insulin resistance and risk of obesity-related cancers

A nutrient-wide association study for risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition and the Netherlands Cohort Study

Papadimitriou, Nikos; Muller, David; van den Brandt, Piet A.; Geybels, Milan et al.

Part of European Journal of Nutrition, p. 2929-2937, 2020

• DOI for A nutrient-wide association study for risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition and the Netherlands Cohort Study
• Download full text (pdf) of A nutrient-wide association study for risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition and the Netherlands Cohort Study

Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study

Lin, E.; Garmo, Hans; Van Hemelrijck, Mieke; Adolfsson, Jan et al.

Part of BMC Cancer, 2020

• DOI for Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study
• Download full text (pdf) of Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study

Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study

Parker, Jonathan; Crawley, Danielle; Garmo, Hans; Lindahl, Bertil et al.

Part of Frontiers in Oncology, 2020

• DOI for Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study
• Download full text (pdf) of Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study

Comparative performance and external validation of the multivariable PREDICTProstatetool for non-metastatic prostate cancer: a study in 69,206 men from Prostate Cancer data Base Sweden (PCBaSe)

Thurtle, David; Bratt, Ola; Stattin, Pär; Pharoah, Paul et al.

Part of BMC Medicine, 2020

• DOI for Comparative performance and external validation of the multivariable PREDICTProstatetool for non-metastatic prostate cancer: a study in 69,206 men from Prostate Cancer data Base Sweden (PCBaSe)
• Download full text (pdf) of Comparative performance and external validation of the multivariable PREDICTProstatetool for non-metastatic prostate cancer: a study in 69,206 men from Prostate Cancer data Base Sweden (PCBaSe)

Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study

Westerberg, Marcus; Franck Lissbrant, Ingela; Damber, Jan Erik; Robinson, David et al.

Part of Acta Oncologica, p. 106-111, 2020

• DOI for Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study
• Download full text (pdf) of Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study

Observational study on time on treatment with abiraterone and enzalutamide

Fallara, Giuseppe; Lissbrant, Ingela Franck; Styrke, Johan; Montorsi, Francesco et al.

Part of PLOS ONE, 2020

• DOI for Observational study on time on treatment with abiraterone and enzalutamide
• Download full text (pdf) of Observational study on time on treatment with abiraterone and enzalutamide

Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study

Thomsen, Frederik B.; Westerberg, Marcus; Garmo, Hans; Robinson, David et al.

Part of PLOS ONE, 2020

• DOI for Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study
• Download full text (pdf) of Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study

Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study

Beckmann, Kerri; Garmo, Hans; Lindahl, Bertil; Holmberg, Lars et al.

Part of Prostate Cancer and Prostatic Diseases, p. 527-533, 2020

• DOI for Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study

Linear age-course effects on the associations between body mass index, triglycerides, and female breast and male liver cancer risk: An internal replication study of 800,000 individuals

Häggström, Christel; Jonsson, Håkan; Björge, Tone; Nagel, Gabriele et al.

Part of International Journal of Cancer, p. 58-67, 2020

• DOI for Linear age-course effects on the associations between body mass index, triglycerides, and female breast and male liver cancer risk: An internal replication study of 800,000 individuals

Anastomotic leakage after anterior resection in patients with rectal cancer previously irradiated for prostate cancer

Sverrisson, Ingvar; Folkvaljon, Folke; Chabok, Abbas; Stattin, Pär et al.

Part of European Journal of Surgical Oncology, p. 341-346, 2019

• DOI for Anastomotic leakage after anterior resection in patients with rectal cancer previously irradiated for prostate cancer

How to measure temporal changes in care pathways for chronic diseases using health care registry data

Ventimiglia, Eugenio; Van Hemelrijck, Mieke; Lindhagen, Lars; Stattin, Pär et al.

Part of BMC Medical Informatics and Decision Making, 2019

• DOI for How to measure temporal changes in care pathways for chronic diseases using health care registry data
• Download full text (pdf) of How to measure temporal changes in care pathways for chronic diseases using health care registry data

Using prognosis to guide inclusion criteria, define standardised endpoints and stratify follow-up in active surveillance for prostate cancer

Gnanapragasam, Vincent J.; Barrett, Tristan; Thankapannair, Vineetha; Thurtle, David et al.

Part of BJU International, p. 758-767, 2019

• DOI for Using prognosis to guide inclusion criteria, define standardised endpoints and stratify follow-up in active surveillance for prostate cancer

Defining Intermediate Risk Prostate Cancer Suitable for Active Surveillance

Loeb, Stacy; Folkvaljon, Yasin; Bratt, Ola; Robinson, David et al.

Part of Journal of Urology, p. 292-299, 2019

• DOI for Defining Intermediate Risk Prostate Cancer Suitable for Active Surveillance

Prostate cancer induces C/EBP expression in surrounding epithelial cells which relates to tumor aggressiveness and patient outcome

Adamo, Hanibal; Hammarsten, Peter; Hägglöf, Christina; Scherdin, Tove Dahl et al.

Part of The Prostate, p. 435-445, 2019

• DOI for Prostate cancer induces C/EBP expression in surrounding epithelial cells which relates to tumor aggressiveness and patient outcome

Mortality after radical prostatectomy in a matched contemporary cohort in Sweden compared to the Scandinavian Prostate Cancer Group 4 (SPCG-4) study

Cazzaniga, Walter; Garmo, Hans; Robinson, David; Holmberg, Lars et al.

Part of BJU International, p. 421-428, 2019

• DOI for Mortality after radical prostatectomy in a matched contemporary cohort in Sweden compared to the Scandinavian Prostate Cancer Group 4 (SPCG-4) study

Androgen deprivation therapy for prostate cancer and risk of dementia

Robinson, David; Garmo, Hans; Van Hemelrijck, Mieke; Damber, Jan-Erik et al.

Part of BJU International, p. 87-92, 2019

• DOI for Androgen deprivation therapy for prostate cancer and risk of dementia
• Download full text (pdf) of Androgen deprivation therapy for prostate cancer and risk of dementia

Population-based, nationwide registration of prostatectomies in Sweden

Cazzaniga, Walter; Godtman, Rebecka Arnsrud; Carlsson, Stefan; Ahlgren, Göran et al.

Part of Journal of Surgical Oncology, p. 803-812, 2019

• DOI for Population-based, nationwide registration of prostatectomies in Sweden
• Download full text (pdf) of Population-based, nationwide registration of prostatectomies in Sweden

Epidemiology of hydrocele and spermatocele; incidence, treatment and complications

Lundström, Karl-Johan; Söderström, Lars; Jernow, Henning; Stattin, Pär et al.

Part of Scandinavian journal of urology, p. 134-138, 2019

• DOI for Epidemiology of hydrocele and spermatocele; incidence, treatment and complications

The Value of an Extensive Transrectal Repeat Biopsy with Anterior Sampling in Men on Active Surveillance for Low-risk Prostate Cancer: A Comparison from the Randomised Study of Active Monitoring in Sweden (SAMS)

Bratt, Ola; Holmberg, Erik; Andren, Ove; Carlsson, Stefan et al.

Part of European Urology, p. 461-466, 2019

• DOI for The Value of an Extensive Transrectal Repeat Biopsy with Anterior Sampling in Men on Active Surveillance for Low-risk Prostate Cancer: A Comparison from the Randomised Study of Active Monitoring in Sweden (SAMS)

Development and validation of a prediction model for identifying men with intermediate- or high-risk prostate cancer for whom bone imaging is unnecessary: a nation-wide population-based study

Arnsrud Godtman, Rebecka; Månsson, Marianne; Bratt, Ola; Robinsson, David et al.

Part of Scandinavian journal of urology, p. 378-384, 2019

• DOI for Development and validation of a prediction model for identifying men with intermediate- or high-risk prostate cancer for whom bone imaging is unnecessary: a nation-wide population-based study

Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome

Hammarsten, Peter; Josefsson, Andreas; Thysell, Elin; Lundholm, Marie et al.

Part of Modern Pathology, p. 1310-1319, 2019

• DOI for Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome
• Download full text (pdf) of Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome

Androgen Deprivation Therapies and Changes in Comorbidity: A Comparison of Gonadotropin-releasing Hormone Agonists and Antiandrogen Monotherapy as Primary Therapy in Men with High-risk Prostate Cancer

Beckmann, Kerri; Garmo, Hans; Adolfsson, Jan; Bosco, Cecilia et al.

Part of European Urology, p. 676-683, 2019

• DOI for Androgen Deprivation Therapies and Changes in Comorbidity: A Comparison of Gonadotropin-releasing Hormone Agonists and Antiandrogen Monotherapy as Primary Therapy in Men with High-risk Prostate Cancer

Anti-androgen monotherapy versus gonadotropin-releasing hormone agonists in men with advanced, non-metastatic prostate cancer: a register-based, observational study

Thomsen, Frederik Birkebaek; Bosco, Cecilia; Garmo, Hans; Adolfsson, Jan et al.

Part of Acta Oncologica, p. 110-118, 2019

• DOI for Anti-androgen monotherapy versus gonadotropin-releasing hormone agonists in men with advanced, non-metastatic prostate cancer: a register-based, observational study
• Download full text (pdf) of Anti-androgen monotherapy versus gonadotropin-releasing hormone agonists in men with advanced, non-metastatic prostate cancer: a register-based, observational study

Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study

Beckmann, Kerri; Russell, Beth; Josephs, Debra; Garmo, Hans et al.

Part of BMC Cancer, 2019

• DOI for Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study
• Download full text (pdf) of Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study

BMI and weight changes and risk of obesity-related cancers: a pooled European cohort study

Bjørge, Tone; Häggström, Christel; Ghaderi, Sara; Nagel, Gabriele et al.

Part of International Journal of Epidemiology, p. 1872-1885, 2019

• DOI for BMI and weight changes and risk of obesity-related cancers: a pooled European cohort study

Serum glucose, triglycerides, and cholesterol in relation to prostate cancer death in the Swedish AMORIS study

Arthur, Rhonda; Møller, Henrik; Garmo, Hans; Häggström, Christel et al.

Part of Cancer Causes and Control, p. 195-206, 2019

• DOI for Serum glucose, triglycerides, and cholesterol in relation to prostate cancer death in the Swedish AMORIS study

The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies

Watts, Eleanor L.; Perez-Cornago, Aurora; Appleby, Paul N.; Albanes, Demetrius et al.

Part of International Journal of Cancer, p. 3244-3256, 2019

• DOI for The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies
• Download full text (pdf) of The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies

Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor

Thysell, Elin; Vidman, Linda; Ylitalo, Erik Bovinder; Jernberg, Emma et al.

Part of Molecular Oncology, p. 1763-1777, 2019

• DOI for Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor
• Download full text (pdf) of Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor

Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening

Assel, Melissa; Dahlin, Anders; Ulmert, David; Bergh, Anders et al.

Part of European Urology, p. 961-967, 2018

• DOI for Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening

Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study

Pettersson, A; Robinson, D; Garmo, H; Holmberg, Lars et al.

Part of Annals of Oncology, p. 377-385, 2018

• DOI for Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study

Concordance of Non-Low-Risk Disease Among Pairs of Brothers With Prostate Cancer

Jansson, Fredrik; Drevin, Linda; Frisell, Thomas; Stattin, Pär et al.

Part of Journal of Clinical Oncology, p. 1847-1852, 2018

• DOI for Concordance of Non-Low-Risk Disease Among Pairs of Brothers With Prostate Cancer

Prostate Cancer Death After Radiotherapy or Radical Prostatectomy: A Nationwide Population-based Observational Study

Robinson, David; Garmo, Hans; Lissbrant, Ingela Franck; Widmark, Anders et al.

Part of European Urology, p. 502-511, 2018

• DOI for Prostate Cancer Death After Radiotherapy or Radical Prostatectomy: A Nationwide Population-based Observational Study
• Download full text (pdf) of Prostate Cancer Death After Radiotherapy or Radical Prostatectomy: A Nationwide Population-based Observational Study

Public online reporting from a nationwide population-based clinical prostate cancer register

Stattin, Pär; Sandin, Fredrik; Loeb, Stacy; Robinson, David et al.

Part of BJU International, p. 8-10, 2018

• DOI for Public online reporting from a nationwide population-based clinical prostate cancer register
• Download full text (pdf) of Public online reporting from a nationwide population-based clinical prostate cancer register

Risk of bladder cancer by disease severity in relation to metabolic factors and smoking: A prospective pooled cohort study of 800,000 men and women

Teleka, Stanley; Häggström, Christel; Nagel, Gabriele; Bjorge, Tone et al.

Part of International Journal of Cancer, p. 3071-3082, 2018

• DOI for Risk of bladder cancer by disease severity in relation to metabolic factors and smoking: A prospective pooled cohort study of 800,000 men and women

Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival

Li, Weiqiang; Middha, Mridu; Bicak, Mesude; Sjoberg, Daniel D. et al.

Part of European Urology, p. 710-719, 2018

• DOI for Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival

Work-up and treatment of prostate cancer before and after publication of the first national guidelines on prostate cancer care in Sweden

Nugin, Hampus; Folkvaljon, Yasin; Damber, Jan-Erik; Adolfsson, Jan et al.

Part of Scandinavian journal of urology, p. 277-284, 2018

• DOI for Work-up and treatment of prostate cancer before and after publication of the first national guidelines on prostate cancer care in Sweden

Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies

Watts, Eleanor L.; Appleby, Paul N.; Perez-Cornago, Aurora; Bueno-de-Mesquita, H. Bas et al.

Part of European Urology, p. 585-594, 2018

• DOI for Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies
• Download full text (pdf) of Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies

Nationwide population-based study on the use of novel antiandrogens in men with prostate cancer in Sweden

Lissbrant, Ingela Franck; Ventimiglia, Eugenio; Robinson, David; Törnblom, Magnus et al.

Part of Scandinavian journal of urology, p. 143-150, 2018

• DOI for Nationwide population-based study on the use of novel antiandrogens in men with prostate cancer in Sweden
• Download full text (pdf) of Nationwide population-based study on the use of novel antiandrogens in men with prostate cancer in Sweden

Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study

Arthur, R.; Williams, R.; Garmo, Hans; Holmberg, Lars et al.

Part of International Journal of Cancer, p. 2254-2262, 2018

• DOI for Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study

Quality Indicators For Global Benchmarking Of Localized Prostate Cancer Management Editorial Comment

Stattin, Pär

Part of Journal of Urology, p. 325-326, 2018

• DOI for Quality Indicators For Global Benchmarking Of Localized Prostate Cancer Management Editorial Comment

Longitudinal study of body mass index, dyslipidemia, hyperglycemia, and hypertension in 60,000 men and women in Sweden and Austria

Van Hemelrijck, Mieke; Ulmer, Hanno; Nagel, Gabriele; Peter, Raphael Simon et al.

Part of PLOS ONE, 2018

• DOI for Longitudinal study of body mass index, dyslipidemia, hyperglycemia, and hypertension in 60,000 men and women in Sweden and Austria
• Download full text (pdf) of Longitudinal study of body mass index, dyslipidemia, hyperglycemia, and hypertension in 60,000 men and women in Sweden and Austria

Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort study

Crawley, Danielle; Garmo, Hans; Rudman, Sarah; Stattin, Pär et al.

Part of BMJ Open, 2018

• DOI for Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort study
• Download full text (pdf) of Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort study

The use of palliative medications before death from prostate cancer: Swedish population-based study with a comparative overview of European data

Lycken, Magdalena; Drevin, Linda; Garmo, Hans; Stattin, Pär et al.

Part of European Journal of Cancer, p. 101-108, 2018

• DOI for The use of palliative medications before death from prostate cancer: Swedish population-based study with a comparative overview of European data

The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

Gnanapragasam, V. J.; Bratt, O.; Muir, K.; Lees, L. S. et al.

Part of BMC Medicine, 2018

• DOI for The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study
• Download full text (pdf) of The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

Diagnosspecifika översikter är viktiga verktyg för cancervården

Stattin, Pär; Franck Lissbrant, Ingela

Part of Läkartidningen, 2018

A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0

Russell, Beth; Garmo, Hans; Beckmann, Kerri; Stattin, Pär et al.

Part of PLOS ONE, 2018

• DOI for A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0
• Download full text (pdf) of A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0

Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitus

Häggström, Christel; Van Hemelrijck, Mieke; Garmo, Hans; Robinson, David et al.

Part of International Journal of Cancer, p. 1868-1875, 2018

• DOI for Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitus
• Download full text (pdf) of Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitus

Socioeconomic status and diagnosis, treatment, and mortality in men with prostate cancer. Nationwide population-based study

Tomic, Katarina; Ventimiglia, Eugenio; Robinson, David; Häggström, Christel et al.

Part of International Journal of Cancer, p. 2478-2484, 2018

• DOI for Socioeconomic status and diagnosis, treatment, and mortality in men with prostate cancer. Nationwide population-based study

Nationwide, population-based study of post radical prostatectomy urinary incontinence correction surgery

Ventimiglia, Eugenio; Folkvaljon, Yasin; Carlsson, Stefan; Bratt, Ola et al.

Part of Journal of Surgical Oncology, p. 321-327, 2018

• DOI for Nationwide, population-based study of post radical prostatectomy urinary incontinence correction surgery
• Download full text (pdf) of Nationwide, population-based study of post radical prostatectomy urinary incontinence correction surgery

Circulating isoflavone and lignan concentrations and prostate cancer risk: a meta-analysis of individual participant data from seven prospective studies including 2,828 cases and 5,593 controls

Perez-Cornago, Aurora; Appleby, Paul N.; Boeing, Heiner; Gil, Leire et al.

Part of International Journal of Cancer, p. 2677-2686, 2018

• DOI for Circulating isoflavone and lignan concentrations and prostate cancer risk: a meta-analysis of individual participant data from seven prospective studies including 2,828 cases and 5,593 controls
• Download full text (pdf) of Circulating isoflavone and lignan concentrations and prostate cancer risk: a meta-analysis of individual participant data from seven prospective studies including 2,828 cases and 5,593 controls

Reply to the letter to the editor 'Age at diagnosis and prognosis among prostate cancer patients treated with radiotherapy: evidenced from three independent cohort studies' by X. Dong, G. Ma and F. Chen

Pettersson, A.; Robinson, D.; Garmo, Hans; Holmberg, Lars et al.

Part of Annals of Oncology, p. 2020-2021, 2018

• DOI for Reply to the letter to the editor 'Age at diagnosis and prognosis among prostate cancer patients treated with radiotherapy: evidenced from three independent cohort studies' by X. Dong, G. Ma and F. Chen

Association between type 2 diabetes, curative treatment and survival in men with intermediate- and high-risk localized prostate cancer.

Crawley, Danielle; Garmo, Hans; Rudman, Sarah; Stattin, Pär et al.

Part of BJU International, p. 209-216, 2018

• DOI for Association between type 2 diabetes, curative treatment and survival in men with intermediate- and high-risk localized prostate cancer.

Drugs for metabolic conditions and prostate cancer death in men on GnRH agonists.

Bosco, Cecilia; Wong, Chloe; Garmo, Hans; Crawley, Danielle et al.

Part of BJU International, p. 260-267, 2018

• DOI for Drugs for metabolic conditions and prostate cancer death in men on GnRH agonists.

Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases

FitzGerald, L. M.; Zhao, S.; Leonardson, A.; Geybels, M. S. et al.

Part of Prostate Cancer and Prostatic Diseases, p. 228-237, 2018

• DOI for Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases
• Download full text (pdf) of Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases

A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor

Licciardello, Marco P.; Ringler, Anna; Markt, Patrick; Klepsch, Freya et al.

Part of Nature Chemical Biology, p. 771-778, 2017

• DOI for A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor

Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study

Stattin, Pär; Sandin, Fredrik; Thomsen, Frederik Birkebk; Garmo, Hans et al.

Part of European Urology, p. 125-134, 2017

• DOI for Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study
• Download full text (pdf) of Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study

Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease: Semi-ecologic, Nationwide, Population-based Study

Thomsen, Frederik Birkebæk; Sandin, Fredrik; Garmo, Hans; Lissbrant, Ingela Franck et al.

Part of European Urology, p. 920-928, 2017

• DOI for Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease: Semi-ecologic, Nationwide, Population-based Study
• Download full text (pdf) of Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease: Semi-ecologic, Nationwide, Population-based Study

Prognostic Significance of Prostate Cancer with Seminal Vesicle Invasion on Radical Prostatectomy: A National Registry Study

Egevad, Lars; Kristiansen, Anna; Drevin, Linda; Delahunt, Brett et al.

Part of Laboratory Investigation, 2017

No difference in risk of cardiovascular disease in men with prostate cancer treated with GnRH agonists or orchiectomy: semi-ecologic, nationwide, population-based study

Thomsen, Frederik B.; Sandin, Fredrik; Garmo, Hans; Lissbrant, Ingela F. et al.

Part of Scandinavian journal of urology, p. 16-16, 2017

• DOI for No difference in risk of cardiovascular disease in men with prostate cancer treated with GnRH agonists or orchiectomy: semi-ecologic, nationwide, population-based study

Use of palliative medications before death from prostate cancer: a population based study

Lycken, Magdalena; Drevin, Linda; Garmo, Hans; Stattin, Pär et al.

Part of Scandinavian journal of urology, p. 25-26, 2017

• DOI for Use of palliative medications before death from prostate cancer: a population based study

Re: Adi J. Klil-Drori, Hui Yin, Vicky Tagalakis, Armen Aprikian, Laurent Azoulay. Androgen Deprivation Therapy for Prostate Cancer and Risk of Venous Thromboembolism Eur Urol 2016;70:56-61

Van Hemelrijck, Mieke; Garmo, Hans; Adolfsson, Jan; Stattin, Pär

Part of European Urology, 2017

• DOI for Re: Adi J. Klil-Drori, Hui Yin, Vicky Tagalakis, Armen Aprikian, Laurent Azoulay. Androgen Deprivation Therapy for Prostate Cancer and Risk of Venous Thromboembolism Eur Urol 2016;70:56-61

Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000-2012

Danneman, Daniela; Drevin, Linda; Delahunt, Brett; Samaratunga, Hemamali et al.

Part of BJU International, p. 50-56, 2017

• DOI for Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000-2012

Associations between prediagnostic blood glucose levels, diabetes, and glioma.

Schwartzbaum, Judith; Edlinger, Michael; Zigmont, Victoria; Stattin, Pär et al.

Part of Scientific Reports, 2017

• DOI for Associations between prediagnostic blood glucose levels, diabetes, and glioma.

Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study

Perez-Cornago, Aurora; Appleby, Paul N; Pischon, Tobias; Tsilidis, Konstantinos K et al.

Part of BMC Medicine, 2017

• DOI for Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study
• Download full text (pdf) of Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study

Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study.

Kristiansen, Anna; Drevin, Linda; Delahunt, Brett; Samaratunga, Hemamali et al.

Part of Pathology, p. 715-720, 2017

• DOI for Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study.

Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer

Häggström, Christel; Van Hemelrijck, Mieke; Zethelius, Björn; Robinson, David et al.

Part of International Journal of Cancer, p. 611-617, 2017

• DOI for Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer
• Download full text (pdf) of Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer

Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men.

Watts, Eleanor L; Appleby, Paul N; Albanes, Demetrius; Black, Amanda et al.

Part of PLOS ONE, 2017

• DOI for Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men.
• Download full text (pdf) of Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men.

Long-term adverse effects after retropubic and robot-assisted radical prostatectomy: Nationwide, population-based study

Fridriksson, Jón Örn; Folkvaljon, Yasin; Lundström, Karl-Johan; Robinson, David et al.

Part of Journal of Surgical Oncology, p. 500-506, 2017

• DOI for Long-term adverse effects after retropubic and robot-assisted radical prostatectomy: Nationwide, population-based study
• Download full text (pdf) of Long-term adverse effects after retropubic and robot-assisted radical prostatectomy: Nationwide, population-based study

Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden

Loeb, Stacy; Folkvaljon, Yasin; Curnyn, Caitlin; Robinson, David et al.

Part of JAMA Oncology, p. 1393-1398, 2017

• DOI for Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden

Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response.

Ylitalo, Erik Bovinder; Thysell, Elin; Jernberg, Emma; Lundholm, Marie et al.

Part of European Urology, p. 776-787, 2017

• DOI for Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response.

Kvaliteten på radikal prostatektomi måste säkerställas - Fortlöpande förbättringsarbete behövs på varje klinik: med patientenkäter kan enskilda kirurgers resultat följas upp

Hugosson, j; Stattin, Pär

Part of Läkartidningen, 2017

Functional Outcomes and Quality of Life After Radical Prostatectomy Only Versus a Combination of Prostatectomy with Radiation and Hormonal Therapy

Adam, Meike; Tennstedt, Pierre; Lanwehr, Dominik; Tilki, Derya et al.

Part of European Urology, p. 330-336, 2017

• DOI for Functional Outcomes and Quality of Life After Radical Prostatectomy Only Versus a Combination of Prostatectomy with Radiation and Hormonal Therapy

Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer

Van Hemelrijck, Mieke; Garmo, Hans; Lindhagen, Lars; Bratt, Ola et al.

Part of European Urology, p. 534-541, 2017

• DOI for Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer
• Download full text (pdf) of Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer

Meta-Analysis of the Association Between Phosphodiesterase Inhibitors (PDE₅Is) and Risk of Melanoma

Loeb, Stacy; Ventimiglia, Eugenio; Salonia, Andrea; Folkvaljon, Yasin et al.

Part of Journal of the National Cancer Institute, 2017

• DOI for Meta-Analysis of the Association Between Phosphodiesterase Inhibitors (PDE₅Is) and Risk of Melanoma
• Download full text (pdf) of Meta-Analysis of the Association Between Phosphodiesterase Inhibitors (PDE₅Is) and Risk of Melanoma

Fruit and vegetable intake and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)

Perez-Cornago, Aurora; Travis, Ruth C.; Appleby, Paul N.; Tsilidis, Konstantinos K. et al.

Part of International Journal of Cancer, p. 287-297, 2017

• DOI for Fruit and vegetable intake and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)
• Download full text (pdf) of Fruit and vegetable intake and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)

Prostate Cancer Radiation Therapy and Risk of Thromboembolic Events

Bosco, Cecilia; Garmo, Hans; Adolfsson, Jan; Stattin, Pär et al.

Part of International Journal of Radiation Oncology, Biology, Physics, p. 1026-1031, 2017

• DOI for Prostate Cancer Radiation Therapy and Risk of Thromboembolic Events
• Download full text (pdf) of Prostate Cancer Radiation Therapy and Risk of Thromboembolic Events

Waiting times for cancer patients in Sweden: A nationwide population-based study

Robertson, Stephanie; Adolfsson, Jan; Stattin, Pär; Sjövall, Annika et al.

Part of Scandinavian Journal of Public Health, p. 230-237, 2017

• DOI for Waiting times for cancer patients in Sweden: A nationwide population-based study

Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer

Loeb, Stacy; Folkvaljon, Yasin; Damber, Jan-Erik; Alukal, Joseph et al.

Part of Journal of Clinical Oncology, p. 1430-1436, 2017

• DOI for Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer
• Download full text (pdf) of Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer

Reply to Glen Denmer Santok and Koon Ho Rha's Letter to the Editor re: Par Stattin, Fredrik Sandin, Frederik Birkebaek Thomsen, et al. Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.07.023

Stattin, Pär; Bratt, Ola

Part of European Urology, 2017

• DOI for Reply to Glen Denmer Santok and Koon Ho Rha's Letter to the Editor re: Par Stattin, Fredrik Sandin, Frederik Birkebaek Thomsen, et al. Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.07.023

Prognostic Significance of Prostate Cancer with Seminal Vesicle Invasion on Radical Prostatectomy: A National Registry Study

Egevad, Lars; Kristiansen, Anna; Drevin, Linda; Delahunt, Brett et al.

Part of Modern Pathology, 2017

• DOI for Prognostic Significance of Prostate Cancer with Seminal Vesicle Invasion on Radical Prostatectomy: A National Registry Study

Small bowel obstruction and abdominal pain after robotic versus open radical prostatectomy

Lundström, Karl-Johan; Folkvaljon, Yasin; Loeb, Stacy; Axelson, Anna Bill et al.

Part of Scandinavian journal of urology, p. 155-159, 2016

• DOI for Small bowel obstruction and abdominal pain after robotic versus open radical prostatectomy

The Proteome of Primary Prostate Cancer.

Iglesias-Gato, Diego; Wikström, Pernilla; Tyanova, Stefka; Lavallee, Charlotte et al.

Part of European Urology, p. 942-52, 2016

• DOI for The Proteome of Primary Prostate Cancer.

Cohort Profile Update: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base--a refined prostate cancer trajectory.

Van Hemelrijck, Mieke; Garmo, Hans; Wigertz, Annette; Nilsson, Per et al.

Part of International Journal of Epidemiology, p. 73-82, 2016

• DOI for Cohort Profile Update: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base--a refined prostate cancer trajectory.

Dashboard report on performance on select quality indicators to cancer care providers

Stattin, Pär; Sandin, Fredrik; Sandback, Torsten; Damber, Jan-Erik et al.

Part of Scandinavian journal of urology, p. 21-28, 2016

• DOI for Dashboard report on performance on select quality indicators to cancer care providers

Reply from Authors re: Matthew T. Gettman. Assessing Work Disability After Radical Prostatectomy. Eur Urol 2016;70:72-3 The Challenge of Assessing Work Disability

Plym, Anna; Voss, Margaretha; Stattin, Pär; Lambe, Mats

Part of European Urology, p. 73-74, 2016

• DOI for Reply from Authors re: Matthew T. Gettman. Assessing Work Disability After Radical Prostatectomy. Eur Urol 2016;70:72-3 The Challenge of Assessing Work Disability

Prognostic Implications of 2005 Gleason Grade Modification. Population-Based Study of Biochemical Recurrence Following Radical Prostatectomy

Thomsen, Frederik B.; Folkvaljon, Yasin; Brasso, Klaus; Loeb, Stacy et al.

Part of Journal of Surgical Oncology, p. 664-670, 2016

• DOI for Prognostic Implications of 2005 Gleason Grade Modification. Population-Based Study of Biochemical Recurrence Following Radical Prostatectomy

Family History and Probability of Prostate Cancer, Differentiated by Risk Category: A Nationwide Population-Based Study

Bratt, Ola; Drevin, Linda; Akre, Olof; Garmo, Hans et al.

Part of Journal of the National Cancer Institute, 2016

• DOI for Family History and Probability of Prostate Cancer, Differentiated by Risk Category: A Nationwide Population-Based Study
• Download full text (pdf) of Family History and Probability of Prostate Cancer, Differentiated by Risk Category: A Nationwide Population-Based Study

Interpretation of conventional survival analysis and competing-risk analysis: an example of hypertension and prostate cancer

Häggström, Christel; Stattin, Pär; Stocks, Tanja; Garmo, Hans et al.

Part of BJU International, p. 850-852, 2016

• DOI for Interpretation of conventional survival analysis and competing-risk analysis: an example of hypertension and prostate cancer
• Download full text (pdf) of Interpretation of conventional survival analysis and competing-risk analysis: an example of hypertension and prostate cancer

Prediction of clinical progression after radical prostatectomy in a nationwide population-based cohort

Bjartell, Anders; Bottai, Matteo; Persson, Josefin; Bratt, Ola et al.

Part of Scandinavian journal of urology, p. 255-259, 2016

• DOI for Prediction of clinical progression after radical prostatectomy in a nationwide population-based cohort

Immediate versus delayed prostatectomy: Nationwide population-based study

Loeb, Stacy; Folkvaljon, Yasin; Robinson, David; Makarov, Danil V. et al.

Part of Scandinavian journal of urology, p. 246-254, 2016

• DOI for Immediate versus delayed prostatectomy: Nationwide population-based study

Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer Treatment

Loeb, Stacy; Folkvaljon, Yasin; Robinson, David; Schlomm, Thorsten et al.

Part of European Urology, p. 824-828, 2016

• DOI for Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer Treatment

Risk of malignant melanoma in men with prostate cancer: Nationwide, population-based cohort study

Thomsen, Frederik B.; Folkvaljon, Yasin; Garmo, Hans; Robinson, David et al.

Part of International Journal of Cancer, p. 2154-2160, 2016

• DOI for Risk of malignant melanoma in men with prostate cancer: Nationwide, population-based cohort study

Further Evidence against a Causal Association between Erectile Dysfunction Drugs and Melanoma

Loeb, Stacy; Stattin, Pär

Part of European Urology, p. 816-817, 2016

• DOI for Further Evidence against a Causal Association between Erectile Dysfunction Drugs and Melanoma

Long-term adverse effects after curative radiotherapy and radical prostatectomy: population-based nationwide register study

Fridriksson, Jon O.; Folkvaljon, Yasin; Nilsson, Per; Robinson, David et al.

Part of Scandinavian journal of urology, p. 338-345, 2016

• DOI for Long-term adverse effects after curative radiotherapy and radical prostatectomy: population-based nationwide register study
• Download full text (pdf) of Long-term adverse effects after curative radiotherapy and radical prostatectomy: population-based nationwide register study

Risk of thromboembolic disease in men with prostate cancer undergoing androgen deprivation

O'Farrell, Sean; Sandström, Karin; Garmo, Hans; Stattin, Pär et al.

Part of BJU International, p. 391-398, 2016

• DOI for Risk of thromboembolic disease in men with prostate cancer undergoing androgen deprivation

Work Disability After Robot-assisted or Open Radical Prostatectomy: A Nationwide, Population-based Study

Plym, Anna; Chiesa, Flaminia; Voss, Margaretha; Holmberg, Lars et al.

Part of European Urology, p. 64-71, 2016

• DOI for Work Disability After Robot-assisted or Open Radical Prostatectomy: A Nationwide, Population-based Study

Re: Editorial Comment on Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma

Loeb, Stacy; Lambe, Mats; Stattin, Pär

Part of Journal of Urology, p. 1172-1173, 2016

Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories

Arthur, Rhonda; Møller, Henrik; Garmo, Hans; Holmberg, Lars et al.

Part of Cancer Medicine, p. 1307-1318, 2016

• DOI for Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories
• Download full text (pdf) of Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories

Extratumoral Heme Oxygenase-1 (HO-1) Expressing Macrophages Likely Promote Primary and Metastatic Prostate Tumor Growth.

Halin Bergström, Sofia; Nilsson, Maria; Adamo, Hanibal; Thysell, Elin et al.

Part of PLOS ONE, 2016

• DOI for Extratumoral Heme Oxygenase-1 (HO-1) Expressing Macrophages Likely Promote Primary and Metastatic Prostate Tumor Growth.

High Caveolin-1 Expression in Tumor Stroma Is Associated with a Favourable Outcome in Prostate Cancer Patients Managed by Watchful Waiting.

Hammarsten, Peter; Dahl Scherdin, Tove; Hägglöf, Christina; Andersson, Pernilla et al.

Part of PLOS ONE, 2016

• DOI for High Caveolin-1 Expression in Tumor Stroma Is Associated with a Favourable Outcome in Prostate Cancer Patients Managed by Watchful Waiting.

Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer

Crawley, Danielle; Garmo, Hans; Rudman, Sarah; Stattin, Pär et al.

Part of International Journal of Cancer, p. 2698-2704, 2016

• DOI for Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer
• Download full text (pdf) of Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer

Svenska kvalitetsregister slår hål på larmrapporter - Register med stora studiepopulationer ger liten risk för fynd baserade på slump eller förväxling.

Stattin, Pär

Part of Läkartidningen, 2016

The roles of stress and social support in prostate cancer mortality

Jan, Michael; Bonn, Stephanie E; Sjölander, Arvid; Wiklund, Fredrik et al.

Part of Scandinavian journal of urology, p. 47-55, 2016

• DOI for The roles of stress and social support in prostate cancer mortality
• Download full text (pdf) of The roles of stress and social support in prostate cancer mortality

Causes of death in men with localized prostate cancer: a nationwide, population-based study.

Van Hemelrijck, Mieke; Folkvaljon, Yasin; Adolfsson, Jan; Akre, Olof et al.

Part of BJU International, p. 507-514, 2016

• DOI for Causes of death in men with localized prostate cancer: a nationwide, population-based study.
• Download full text (pdf) of Causes of death in men with localized prostate cancer: a nationwide, population-based study.

Selenium and Prostate Cancer: Analysis of Individual Participant Data From Fifteen Prospective Studies.

Allen, Naomi E; Travis, Ruth C; Appleby, Paul N; Albanes, Demetrius et al.

Part of Journal of the National Cancer Institute, 2016

• DOI for Selenium and Prostate Cancer: Analysis of Individual Participant Data From Fifteen Prospective Studies.

Longitudinal biobanks-based study on the joint effects of infections, nutrition and hormones on risk of prostate cancer.

Lumme, Sonja; Tenkanen, Leena; Langseth, Hilde; Gislefoss, Randi et al.

Part of Acta Oncologica, p. 839-45, 2016

• DOI for Longitudinal biobanks-based study on the joint effects of infections, nutrition and hormones on risk of prostate cancer.

Circulating Folate and Vitamin B12 and Risk of Prostate Cancer: A Collaborative Analysis of Individual Participant Data from Six Cohorts Including 6875 Cases and 8104 Controls.

Price, Alison J; Travis, Ruth C; Appleby, Paul N; Albanes, Demetrius et al.

Part of European Urology, p. 941-951, 2016

• DOI for Circulating Folate and Vitamin B12 and Risk of Prostate Cancer: A Collaborative Analysis of Individual Participant Data from Six Cohorts Including 6875 Cases and 8104 Controls.

Snus use, smoking and survival among prostate cancer patients.

Wilson, Kathryn M; Markt, Sarah C; Fang, Fang; Nordenvall, Caroline et al.

Part of International Journal of Cancer, p. 2753-2759, 2016

• DOI for Snus use, smoking and survival among prostate cancer patients.

International cancer seminars: a focus on kidney cancer.

Scelo, G; Hofmann, J N; Banks, R E; Bigot, P et al.

Part of Annals of Oncology, p. 1382-5, 2016

• DOI for International cancer seminars: a focus on kidney cancer.

Clinical characteristics and primary management of patients diagnosed with prostate cancer between 2007 and 2013: status from a Danish primary referral center

Thomsen, Frederik B.; Mikkelsen, Marta K.; Hansen, Rikke B.; Krug, Andrea H. et al.

Part of Acta Oncologica, p. 1456-1460, 2016

• DOI for Clinical characteristics and primary management of patients diagnosed with prostate cancer between 2007 and 2013: status from a Danish primary referral center

Proportion and characteristics of men with unknown risk category in the National Prostate Cancer Register of Sweden

Tomic, Katarina; Westerberg, Marcus; Robinson, David; Garmo, Hans et al.

Part of Acta Oncologica, p. 1461-1466, 2016

• DOI for Proportion and characteristics of men with unknown risk category in the National Prostate Cancer Register of Sweden

Phosphodiesterase type 5 inhibitors (PDE5i) and prostate cancer recurrence

Loeb, Stacy; Folkvaljon, Yasin; Robinson, David; Schlomm, Thorsten et al.

Part of Journal of Clinical Oncology, 2016

Postoperative mortality 90 days after robot-assisted laparoscopic prostatectomy and retropubic radical prostatectomy: a nationwide population-based study

Björklund, Johan; Folkvaljon, Yasin; Cole, Alexander; Carlsson, Stefan et al.

Part of BJU International, p. 302-306, 2016

• DOI for Postoperative mortality 90 days after robot-assisted laparoscopic prostatectomy and retropubic radical prostatectomy: a nationwide population-based study

A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

Travis, Ruth C.; Appleby, Paul N.; Martin, Richard M.; Holly, Jeff M. P. et al.

Part of Cancer Research, p. 2288-2300, 2016

• DOI for A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

Evaluation of the 2015 Gleason Grade Groups in a Nationwide Population-based Cohort

Loeb, Stacy; Folkvaljon, Yasin; Robinson, David; Lissbrant, Ingela Franck et al.

Part of European Urology, p. 1135-1141, 2016

• DOI for Evaluation of the 2015 Gleason Grade Groups in a Nationwide Population-based Cohort

Re: Giorgio Gandaglia, Freddie Bray, Matthew R. Cooperberg, et al. Prostate Cancer Registries: Current Status and Future Directions. Eur Urol 2015;68:e110

Stattin, Pär; Robinson, David; Lambe, Mats

Part of European Urology, 2015

• DOI for Re: Giorgio Gandaglia, Freddie Bray, Matthew R. Cooperberg, et al. Prostate Cancer Registries: Current Status and Future Directions. Eur Urol 2015;68:e110

Capture rate and representativity of The National Prostate Cancer Register of Sweden

Tomic, Katarina; Berglund, Anders; Robinson, David; Hjälm-Eriksson, Marie et al.

Part of Acta Oncologica, p. 158-163, 2015

• DOI for Capture rate and representativity of The National Prostate Cancer Register of Sweden
• Download full text (pdf) of Capture rate and representativity of The National Prostate Cancer Register of Sweden

Gleason inflation 1998-2011: a registry study of 97,168 men

Danneman, Daniela; Drevin, Linda; Robinson, David; Stattin, Pär et al.

Part of BJU International, p. 248-55, 2015

• DOI for Gleason inflation 1998-2011: a registry study of 97,168 men
• Download full text (pdf) of Gleason inflation 1998-2011: a registry study of 97,168 men

An investigation into the relationship between Statins and Cancer using population-based data

Melvin, Jennifer C; Garmo, Hans; Daniel, Rhian; Shanmugalingam, Thurkaa et al.

Part of BJU International, p. 681-683, 2015

• DOI for An investigation into the relationship between Statins and Cancer using population-based data

Correlation of Gleason Score in Biopsy and Radical Prostatectomy Specimens 2000-2012-A Registry Study of 15598 Men

Egevad, Lars; Danneman, Daniela; Stattin, Pär; Drevin, Linda

Part of Laboratory Investigation, 2015

ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3)

Markt, Sarah C; Shui, Irene M; Unger, Robert H; Urun, Yuksel et al.

Part of The Prostate, p. 1677-81, 2015

• DOI for ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3)
• Download full text (pdf) of ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3)

Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer

Bratt, Ola; Folkvaljon, Yasin; Eriksson, Marie Hjalm; Akre, Olof et al.

Part of European Urology, p. 53-58, 2015

• DOI for Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer
• Download full text (pdf) of Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer

Five-year Nationwide Follow-up Study of Active Surveillance for Prostate Cancer

Loeb, Stacy; Folkvaljon, Yasin; Makarov, Danil V.; Bratt, Ola et al.

Part of European Urology, p. 233-238, 2015

• DOI for Five-year Nationwide Follow-up Study of Active Surveillance for Prostate Cancer

Secreted Factors from Colorectal and Prostate Cancer Cells Skew the Immune Response in Opposite Directions.

Lundholm, Marie; Hägglöf, Christina; Wikberg, Maria L; Stattin, Pär et al.

Part of Scientific Reports, 2015

• DOI for Secreted Factors from Colorectal and Prostate Cancer Cells Skew the Immune Response in Opposite Directions.

How to model temporal changes in comorbidity for cancer patients using prospective cohort data

Lindhagen, Lars; Van Hemelrijck, Mieke; Robinson, David; Stattin, Pär et al.

Part of BMC Medical Informatics and Decision Making, 2015

• DOI for How to model temporal changes in comorbidity for cancer patients using prospective cohort data
• Download full text (pdf) of How to model temporal changes in comorbidity for cancer patients using prospective cohort data

Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort Study

Robinson, David; Garmo, Hans; Stattin, Pär; Michaëlsson, Karl

Part of PLOS ONE, 2015

• DOI for Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort Study
• Download full text (pdf) of Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort Study

High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting

Nilsson, Maria; Hägglöf, Christina; Hammarsten, Peter; Thysell, Elin et al.

Part of PLOS ONE, 2015

• DOI for High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting
• Download full text (pdf) of High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting

Evaluation of data quality in the National Prostate Cancer Register of Sweden

Tomic, Katarina; Sandin, Fredrik; Wigertz, Annette; Robinson, David et al.

Part of European Journal of Cancer, p. 101-111, 2015

• DOI for Evaluation of data quality in the National Prostate Cancer Register of Sweden

Diabetes mellitus and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition

Tsilidis, Konstantinos K; Allen, Naomi E; Appleby, Paul N; Rohrmann, Sabine et al.

Part of International Journal of Cancer, p. 372-81, 2015

• DOI for Diabetes mellitus and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition
• Download full text (pdf) of Diabetes mellitus and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition

Mortality in older men with low-risk prostate cancer and high comorbidity

Stattin, Pär

Part of Journal of Clinical Oncology, p. 1086-1087, 2015

• DOI for Mortality in older men with low-risk prostate cancer and high comorbidity

Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study

Stattin, Pär; Vickers, Andrew J; Sjoberg, Daniel D; Johansson, Robert et al.

Part of European Urology, p. 207-213, 2015

• DOI for Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study

Physical activity and survival among men diagnosed with prostate cancer

Bonn, Stephanie E; Sjölander, Arvid; Lagerros, Ylva Trolle; Wiklund, Fredrik et al.

Part of Cancer Epidemiology, Biomarkers and Prevention, p. 57-64, 2015

• DOI for Physical activity and survival among men diagnosed with prostate cancer

Physical activity and body mass index as predictors of prostate cancer risk

Grotta, Alessandra; Bottai, Matteo; Adami, Hans-Olov; Adams, Swann Arp et al.

Part of World journal of urology, p. 1495-1502, 2015

• DOI for Physical activity and body mass index as predictors of prostate cancer risk

Insufficient Sleep and Risk of Prostate Cancer in a Large Swedish Cohort.

Markt, Sarah C; Grotta, Alessandra; Nyren, Olof; Adami, Hans-Olov et al.

Part of Sleep, p. 1405-10, 2015

• DOI for Insufficient Sleep and Risk of Prostate Cancer in a Large Swedish Cohort.

Metabolic risk score and cancer risk: pooled analysis of seven cohorts

Stocks, Tanja; Bjørge, Tone; Ulmer, Hanno; Manjer, Jonas et al.

Part of International Journal of Epidemiology, p. 1353-1363, 2015

• DOI for Metabolic risk score and cancer risk: pooled analysis of seven cohorts
• Download full text (pdf) of Metabolic risk score and cancer risk: pooled analysis of seven cohorts

Associations Do Not Equal Causation: Clinical Relevance of Statistical Associations of Phosphodiesterase Type 5 Inhibitors with Prostate Cancer Progression and Melanoma.

Loeb, Stacy; Schlomm, Thorsten; Stattin, Pär

Part of European Urology, p. 754-755, 2015

• DOI for Associations Do Not Equal Causation: Clinical Relevance of Statistical Associations of Phosphodiesterase Type 5 Inhibitors with Prostate Cancer Progression and Melanoma.

Risk and Timing of Cardiovascular Disease After Androgen-Deprivation Therapy in Men With Prostate Cancer

O'Farrell, Sean; Garmo, Hans; Holmberg, Lars; Adolfsson, Jan et al.

Part of Journal of Clinical Oncology, p. 1243-1251, 2015

• DOI for Risk and Timing of Cardiovascular Disease After Androgen-Deprivation Therapy in Men With Prostate Cancer

Upper limit of cancer extent on biopsy defining very low-risk prostate cancer

Bratt, Ola; Folkvaljon, Yasin; Loeb, Stacy; Klotz, Laurence et al.

Part of BJU International, p. 213-219, 2015

• DOI for Upper limit of cancer extent on biopsy defining very low-risk prostate cancer

Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma

Loeb, Stacy; Folkvaljon, Yasin; Lambe, Mats; Robinson, David et al.

Part of Journal of the American Medical Association (JAMA), p. 2449-2455, 2015

• DOI for Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma

Constrained randomization and multivariate effect projections improve information extraction and biomarker pattern discovery in metabolomics studies involving dependent samples.

Jonsson, Pär; Wuolikainen, Anna; Thysell, Elin; Chorell, Elin et al.

Part of Metabolomics, p. 1667-1678, 2015

• DOI for Constrained randomization and multivariate effect projections improve information extraction and biomarker pattern discovery in metabolomics studies involving dependent samples.
• Download full text (pdf) of Constrained randomization and multivariate effect projections improve information extraction and biomarker pattern discovery in metabolomics studies involving dependent samples.

5-alpha reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer

Robinson, David; Garmo, Hans; Holmberg, Lars; Stattin, Pär

Part of Cancer Causes and Control, p. 1289-1297, 2015

• DOI for 5-alpha reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer
• Download full text (pdf) of 5-alpha reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer

Incidence of groin hernia repair after radical prostatectomy: a population-based nationwide study.

Nilsson, Hanna; Stranne, Johan; Stattin, Pär; Nordin, Pär

Part of Annals of Surgery, p. 1223-1227, 2014

• DOI for Incidence of groin hernia repair after radical prostatectomy: a population-based nationwide study.

"To measure is to know. If you cannot measure it, you cannot improve it": Statistical modeling cannot compensate for unmeasured bias

Stattin, Pär; Loeb, Stacy

Part of European Urology, p. 701-703, 2014

• DOI for "To measure is to know. If you cannot measure it, you cannot improve it": Statistical modeling cannot compensate for unmeasured bias

Prostate cancer mortality in areas with high and low prostate cancer incidence

Stattin, Pär; Carlsson, Sigrid; Holmström, Benny; Vickers, Andrew et al.

Part of Journal of the National Cancer Institute, 2014

• DOI for Prostate cancer mortality in areas with high and low prostate cancer incidence
• Download full text (pdf) of Prostate cancer mortality in areas with high and low prostate cancer incidence

Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project

Lindkvist, Björn; Johansen, Dorthe; Stocks, Tanja; Concin, Hans et al.

Part of BMC Cancer, p. 103, 2014

• DOI for Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project

TMPRSS2-ERG expression predicts prostate cancer survival and associates with stromal biomarkers.

Hägglöf, Christina; Hammarsten, Peter; Strömvall, Kerstin; Egevad, Lars et al.

Part of PLOS ONE, 2014

• DOI for TMPRSS2-ERG expression predicts prostate cancer survival and associates with stromal biomarkers.
• Download full text (pdf) of TMPRSS2-ERG expression predicts prostate cancer survival and associates with stromal biomarkers.

A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study

Borena, Wegene; Edlinger, Michael; Bjørge, Tone; Häggström, Christel et al.

Part of PLOS ONE, 2014

• DOI for A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study

Fathering of Dizygotic Twins and Risk of Prostate Cancer: Nationwide, Population-Based Case-Control Study

Wiren, Sara; Drevin, Linda; Akre, Olof; Robinson, David et al.

Part of PLOS ONE, 2014

• DOI for Fathering of Dizygotic Twins and Risk of Prostate Cancer: Nationwide, Population-Based Case-Control Study

Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

Wang, Zhaoming; Zhu, Bin; Zhang, Mingfeng; Parikh, Hemang et al.

Part of Human Molecular Genetics, p. 6616-6633, 2014

• DOI for Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

Pooled cohort study on height and risk of cancer and cancer death

Wirén, Sara; Häggström, Christel; Ulmer, Hanno; Manjer, Jonas et al.

Part of Cancer Causes and Control, p. 151-159, 2014

• DOI for Pooled cohort study on height and risk of cancer and cancer death

Body mass index and weight change in men with prostate cancer: progression and mortality.

Bonn, Stephanie E; Wiklund, Fredrik; Sjölander, Arvid; Szulkin, Robert et al.

Part of Cancer Causes and Control, p. 933-943, 2014

• DOI for Body mass index and weight change in men with prostate cancer: progression and mortality.

High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome.

Tidehag, Viktor; Hammarsten, Peter; Egevad, Lars; Granfors, Torvald et al.

Part of European Journal of Cancer, p. 1829-1835, 2014

• DOI for High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome.

Prostate cancer, prostate cancer death, and death from other causes, among men with metabolic aberrations

Häggström, Christel; Stocks, Tanja; Nagel, Gabriele; Manjer, Jonas et al.

Part of Epidemiology, p. 823-828, 2014

• DOI for Prostate cancer, prostate cancer death, and death from other causes, among men with metabolic aberrations

Response

Stattin, Pär; Carlsson, Sigrid; Jonsson, Håkan

Part of Journal of the National Cancer Institute, 2014

• DOI for Response
• Download full text (pdf) of Response

Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies.

Crowe, Francesca L; Appleby, Paul N; Travis, Ruth C; Barnett, Matt et al.

Part of Journal of the National Cancer Institute, 2014

• DOI for Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies.
• Download full text (pdf) of Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies.

Population Based Study of Predictors of Adverse Pathology among Candidates for Active Surveillance with Gleason 6 Prostate Cancer

Vellekoop, Annelies; Loeb, Stacy; Folkvaljon, Yasin; Stattin, Pär

Part of Journal of Urology, p. 350-357, 2014

• DOI for Population Based Study of Predictors of Adverse Pathology among Candidates for Active Surveillance with Gleason 6 Prostate Cancer

The Value of Real-World Data in Understanding Prostate Cancer Risk and Improving Clinical Care: Examples from Swedish Registries

Beckmann, Kerri; Garmo, Hans; Franck Lissbrant, Ingela; Stattin, Pär

Part of Cancers, 2021

• DOI for The Value of Real-World Data in Understanding Prostate Cancer Risk and Improving Clinical Care: Examples from Swedish Registries
• Download full text (pdf) of The Value of Real-World Data in Understanding Prostate Cancer Risk and Improving Clinical Care: Examples from Swedish Registries

Mini Review on the Use of Clinical Cancer Registers for Prostate Cancer: The National Prostate Cancer Register (NPCR) of Sweden

Cazzaniga, Walter; Ventimiglia, Eugenio; Alfano, Massimo; Robinson, David et al.

Part of Frontiers in Medicine, 2019

• DOI for Mini Review on the Use of Clinical Cancer Registers for Prostate Cancer: The National Prostate Cancer Register (NPCR) of Sweden
• Download full text (pdf) of Mini Review on the Use of Clinical Cancer Registers for Prostate Cancer: The National Prostate Cancer Register (NPCR) of Sweden

Factors Influencing Men's Choice of and Adherence to Active Surveillance for Low-risk Prostate Cancer: A Mixed-method Systematic Review

Kinsella, Netty; Stattin, Pär; Cahill, Declan; Brown, Christian et al.

Part of European Urology, p. 261-280, 2018

• DOI for Factors Influencing Men's Choice of and Adherence to Active Surveillance for Low-risk Prostate Cancer: A Mixed-method Systematic Review

A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus

Crawley, Danielle; Chamberlain, Florence; Garmo, Hans; Rudman, Sarah et al.

Part of ecancermedicalscience, 2018

• DOI for A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus
• Download full text (pdf) of A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus

Different assumptions about missingness in registration of metastatic status have important implications for following trends in cancer presentation

Westerberg, Marcus; Beckman, Kerri; Gedeborg, Rolf; Irenaeus, Sandra et al.